• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IDT
Click for more information
0.00% 10.0¢

IDT AUSTRALIA LIMITED - Announcements

Market Cap $51.58M  ! watchlist Created with Sketch. Add to my watchlist

IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged... IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities produces both API and FDF across the medicinal cannabis manufacturing space. It also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IDTAnnual Report to shareholders25/10/12
IDTNotice of deferred AGM / Proxy19/10/12
IDTLetter to shareholders re deferral of AGM11/10/12
IDTNotice of Annual General Meeting/Proxy Form25/09/12
IDTFull Year Statutory Accounts27/08/12
IDTPreliminary Final ReportPRICE SENSITIVE23/08/12
IDTChange of Director's Interest Notice18/05/12
IDTBusiness UpdatePRICE SENSITIVE17/05/12
IDTProfit GuidancePRICE SENSITIVE01/05/12
IDTInitial Director's Interest Notice20/03/12
IDTDirector Appointment/Resignation20/03/12
IDTHalf Year Accounts17/02/12
IDTHalf Yearly Report and AccountsPRICE SENSITIVE17/02/12
IDTResults of Meeting28/10/11
IDTChairman's Address to Shareholders28/10/11
IDTProfit updatePRICE SENSITIVE04/10/11
IDTNotice of Annual General Meeting/Proxy Form27/09/11
IDTAnnual Report to shareholders18/08/11
IDTPreliminary Final ReportPRICE SENSITIVE17/08/11
IDTIDT secures government grant for innovative anti cancer drugPRICE SENSITIVE19/07/11
IDTAmended Appendix 3Y30/06/11
IDTChange of Director's Interest Notice30/06/11
IDTMarket UpdatePRICE SENSITIVE27/04/11
IDTChange of Director's Interest Notice01/04/11
IDTChange of Director's Interest Notice01/04/11
IDTChange of Director's Interest Notice01/04/11
IDTChange of Director's Interest Notice01/04/11
IDTChange of Director's Interest Notice01/04/11
IDTChange of Director's Interest Notice01/04/11
IDTLapse of Unlisted Options22/02/11
IDTAppendix 4D Half Year ReportPRICE SENSITIVE22/02/11
IDTHalf Year Accounts22/02/11
IDTShare Trading Policy21/12/10
IDTResults of Meeting29/10/10
IDTAGM Presentation29/10/10
IDTChairman and Managing Directors Address to AGM29/10/10
IDTCompany Secretary Appointment27/10/10
IDTAnnual Report to shareholders27/09/10
IDTNotice of Annual General Meeting/Proxy Form27/09/10
IDTNew CFO Appointed01/09/10
IDTPreliminary Final ReportPRICE SENSITIVE23/08/10
IDTAppendix 3B22/07/10
IDTChange of Director's Interest Notice30/04/10
IDTChange of Director's Interest Notice30/04/10
IDTChange of Director's Interest Notice29/04/10
IDTChange of Director's Interest Notice29/04/10
IDTChange of Director's Interest Notice29/04/10
IDTChange of Director's Interest Notice29/04/10
IDTConfirmation of Allotment of Bonus Options27/04/10
IDTRevised Prospectus Timetable and Appendix 3BPRICE SENSITIVE14/04/10
IDTBonus Option Offer ProspectusPRICE SENSITIVE14/04/10
IDTPFIZER ASSETS TRANSFERRED AND EARNINGS GUIDANCEPRICE SENSITIVE12/04/10
IDTAppendix 3B06/04/10
IDTResponse to a ASX Price QueryPRICE SENSITIVE06/04/10
ACL +SandP Announces March SP/ASX Index Rebalance05/03/10
IDTAppendix 3B18/02/10
IDTHalf Yearly Report and AccountsPRICE SENSITIVE16/02/10
IDTResults of Meeting30/10/09
IDTManaging Director Powerpoint Presentation30/10/09
IDTChairman's and Managing Directors Address at AGM30/10/09
IDTAnnual Report to shareholders29/09/09
IDTNotice of Annual General Meeting/Proxy Form29/09/09
IDTPreliminary Final ReportPRICE SENSITIVE18/08/09
IDTResponse to an ASX Query - Corporate Governance22/07/09
IDTResponse to ASX Query - Director's Interest Notice07/05/09
IDTChange of Director's Interest Notice x 528/04/09
ABB +SandP Announces March SP/ASX Index Rebalance06/03/09
IDTHalf Yearly Report and AccountsPRICE SENSITIVE17/02/09
IDTMarket UpdatePRICE SENSITIVE23/12/08
IDTAnnual Report to shareholders
25/10/12
IDTNotice of deferred AGM / Proxy
19/10/12
IDTLetter to shareholders re deferral of AGM
11/10/12
IDTNotice of Annual General Meeting/Proxy Form
25/09/12
IDTFull Year Statutory Accounts
27/08/12
IDTPreliminary Final Report
23/08/12PRICE SENSITIVE
IDTChange of Director's Interest Notice
18/05/12
IDTBusiness Update
17/05/12PRICE SENSITIVE
IDTProfit Guidance
01/05/12PRICE SENSITIVE
IDTInitial Director's Interest Notice
20/03/12
IDTDirector Appointment/Resignation
20/03/12
IDTHalf Year Accounts
17/02/12
IDTHalf Yearly Report and Accounts
17/02/12PRICE SENSITIVE
IDTResults of Meeting
28/10/11
IDTChairman's Address to Shareholders
28/10/11
IDTProfit update
04/10/11PRICE SENSITIVE
IDTNotice of Annual General Meeting/Proxy Form
27/09/11
IDTAnnual Report to shareholders
18/08/11
IDTPreliminary Final Report
17/08/11PRICE SENSITIVE
IDTIDT secures government grant for innovative anti cancer drug
19/07/11PRICE SENSITIVE
IDTAmended Appendix 3Y
30/06/11
IDTChange of Director's Interest Notice
30/06/11
IDTMarket Update
27/04/11PRICE SENSITIVE
IDTChange of Director's Interest Notice
01/04/11
IDTChange of Director's Interest Notice
01/04/11
IDTChange of Director's Interest Notice
01/04/11
IDTChange of Director's Interest Notice
01/04/11
IDTChange of Director's Interest Notice
01/04/11
IDTChange of Director's Interest Notice
01/04/11
IDTLapse of Unlisted Options
22/02/11
IDTAppendix 4D Half Year Report
22/02/11PRICE SENSITIVE
IDTHalf Year Accounts
22/02/11
IDTShare Trading Policy
21/12/10
IDTResults of Meeting
29/10/10
IDTAGM Presentation
29/10/10
IDTChairman and Managing Directors Address to AGM
29/10/10
IDTCompany Secretary Appointment
27/10/10
IDTAnnual Report to shareholders
27/09/10
IDTNotice of Annual General Meeting/Proxy Form
27/09/10
IDTNew CFO Appointed
01/09/10
IDTPreliminary Final Report
23/08/10PRICE SENSITIVE
IDTAppendix 3B
22/07/10
IDTChange of Director's Interest Notice
30/04/10
IDTChange of Director's Interest Notice
30/04/10
IDTChange of Director's Interest Notice
29/04/10
IDTChange of Director's Interest Notice
29/04/10
IDTChange of Director's Interest Notice
29/04/10
IDTChange of Director's Interest Notice
29/04/10
IDTConfirmation of Allotment of Bonus Options
27/04/10
IDTRevised Prospectus Timetable and Appendix 3B
14/04/10PRICE SENSITIVE
IDTBonus Option Offer Prospectus
14/04/10PRICE SENSITIVE
IDTPFIZER ASSETS TRANSFERRED AND EARNINGS GUIDANCE
12/04/10PRICE SENSITIVE
IDTAppendix 3B
06/04/10
IDTResponse to a ASX Price Query
06/04/10PRICE SENSITIVE
ACL +SandP Announces March SP/ASX Index Rebalance
05/03/10
IDTAppendix 3B
18/02/10
IDTHalf Yearly Report and Accounts
16/02/10PRICE SENSITIVE
IDTResults of Meeting
30/10/09
IDTManaging Director Powerpoint Presentation
30/10/09
IDTChairman's and Managing Directors Address at AGM
30/10/09
IDTAnnual Report to shareholders
29/09/09
IDTNotice of Annual General Meeting/Proxy Form
29/09/09
IDTPreliminary Final Report
18/08/09PRICE SENSITIVE
IDTResponse to an ASX Query - Corporate Governance
22/07/09
IDTResponse to ASX Query - Director's Interest Notice
07/05/09
IDTChange of Director's Interest Notice x 5
28/04/09
ABB +SandP Announces March SP/ASX Index Rebalance
06/03/09
IDTHalf Yearly Report and Accounts
17/02/09PRICE SENSITIVE
IDTMarket Update
23/12/08PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
10.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $51.58M
Open High Low Value Volume
10.5¢ 10.5¢ 10.0¢ $32.31K 322.8K

Buyers (Bids)

No. Vol. Price($)
3 237153 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 114864 5
View Market Depth
Last trade - 13.13pm 22/11/2024 (20 minute delay) ?
Last
10.0¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
10.0¢ 10.0¢ 10.0¢ 25852
Last updated 13.46pm 22/11/2024 ?
IDT (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.